Mounjaro®
Starting from £179.99/mo
Start journey Learn moreMissing a period on Mounjaro is more common than many people expect. Tirzepatide changes how your body handles insulin, fat storage and hormones involved in the reproductive cycle, so menstrual disruption (including lighter, delayed or absent periods) has been reported by women across every stage of treatment. These are prescription-only medicines that require a clinical assessment before a prescriber decides whether they're suitable for you; if your cycle has changed significantly since starting, that conversation is worth having sooner rather than later. This page explains the biological reasons behind it, what the clinical picture looks like, and when a missed period needs more attention than just a diary note. For a broader picture of how tirzepatide can affect the menstrual cycle overall, that page covers the full range of changes women describe.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
Picture this: you're six or eight weeks into treatment, things are going well, and then your period simply doesn't show up. No cramps beforehand, no spotting, nothing. The instinct for many women is to reach for a pregnancy test. That's reasonable, and ruling it out is always the right first step. But for a significant number of people on Mounjaro, the answer isn't pregnancy, it's the treatment itself working as intended, with some collateral effects on the hormonal systems that regulate the menstrual cycle.
The core mechanism sits at the intersection of energy balance and reproduction. When caloric intake drops sharply (as it typically does when appetite suppression kicks in) the hypothalamus can dial back production of gonadotropin-releasing hormone (GnRH). That signal cascade is what tells the pituitary to release LH and FSH, which in turn drive ovulation. Less fuel coming in reads, biologically, as a signal that this may not be the right moment for reproduction. The result can be a delayed or absent period. This is the same mechanism behind missed periods in athletes in heavy training or anyone with a very restricted diet, and it is well recognised in the context of significant weight change.
Tirzepatide adds another layer. As a dual GIP and GLP-1 receptor agonist (the only medicine of its kind licensed in the UK for weight management) it meaningfully improves insulin sensitivity. Since insulin interacts with the enzymes that regulate oestrogen production in adipose tissue, a shift in that balance can alter where oestrogen sits in your cycle at any given point. Lighter, shorter or simply absent periods are all plausible downstream effects. The tirzepatide overview explains more about how the medicine works at a receptor level.
Menstrual changes tend to show up within the first two to three months of treatment, roughly in step with when weight loss becomes noticeable. For many women, cycles stabilise once weight loss plateaus or the pace of change slows, the body adjusts. For others, irregularity continues for as long as treatment continues at a therapeutically active dose.
One misconception worth gently setting aside: absent periods on Mounjaro do not mean you cannot get pregnant. Ovulation can happen without a predictable cycle, and there is reasonable evidence that improving insulin sensitivity (particularly relevant for women with PCOS, where hyperinsulinaemia suppresses ovulation) can actually restore fertility in women who previously had difficulty conceiving. The NHS England guidance on Mounjaro and periods reinforces that effective contraception is important throughout treatment precisely because of this. For women using oral contraceptives, tirzepatide's effect on gastric emptying can reduce pill absorption in the first four weeks of treatment and for four weeks after any dose increase; adding a barrier method during those windows is the practical fix.
The MHRA and NHS both note that women who are pregnant, breastfeeding or actively trying to conceive should not use tirzepatide. If a period is late and pregnancy is a possibility, a test and a conversation with your GP or prescriber should happen before taking your next dose. Details on period pain and Mounjaro are on a separate page if cramping patterns have also changed.
Most cycle changes on Mounjaro are not a medical emergency. One missed period, no other symptoms, confirmed-negative pregnancy test, watch and wait for another cycle while keeping your prescriber informed. That's a proportionate response.
The situation warrants faster action if: periods have been absent for three or more consecutive cycles; you have significant pelvic pain, unexpected bleeding between cycles, or other new symptoms; you have a history of thyroid conditions, polycystic ovary syndrome, premature ovarian insufficiency or a hypopituitary condition; or the pregnancy test is positive. In any of those cases, contact your GP. Treatment may need to pause, or investigations may be appropriate before continuing.
From a wider perspective on safe supply, Mounjaro is a prescription-only medicine that requires clinical assessment, a prescriber reviews your full health picture, not just your BMI, before any dose is issued or continued. That review is also the right moment to raise menstrual changes. The NHS England guidance on weight-management injections covers reproductive health considerations in useful detail.
A few things that make a real difference:
First, rule out pregnancy with a test, ideally taken on the day the period was expected or shortly after. Second, note in a diary or app when the change started relative to your Mounjaro start date and current dose, that chronology helps a prescriber assess whether the timing fits the treatment or points elsewhere. Third, make sure protein intake is adequate. One underappreciated effect of appetite suppression is that some women reduce protein significantly, which compounds the energy-deficit signal to the hypothalamus; if you're also rethinking what to eat more broadly, our guide to eating grapes on Mounjaro is a useful example of how to think about fruit and sugar intake during treatment. A brief word with a dietitian can be genuinely useful here, and our FAQs address some common nutrition questions on treatment.
Fourth (and this is practical rather than alarming) keep contraception in place. The NHS's position is clear: do not assume an irregular or absent cycle means you cannot ovulate. Finally, if you're uncertain about any of this, our team is available seven days a week. Bring it up at your next clinical review, or raise it sooner. Prescribers at nume personally review every consultation, and changes to your cycle are exactly the kind of thing that warrants a note. The NHS tirzepatide patient page also lists hormonal changes among effects to discuss with a healthcare professional. If you haven't yet started treatment and want to understand your options, a free consultation is the first step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.